loadpatents
name:-0.0093479156494141
name:-0.011219024658203
name:-0.0013401508331299
Neuromed Technologies, Inc. Patent Filings

Neuromed Technologies, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Neuromed Technologies, Inc..The latest application filed is for "calcium channel blockers comprising two benzhydril moieties".

Company Profile
0.11.6
  • Neuromed Technologies, Inc. - Vancouver CA
  • NeuroMed Technologies Inc. -
  • Neuromed Technologies, Inc. - Silver Spring MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nucleic acids encoding mammalian T-type calcium channels
Grant 7,501,263 - Snutch , et al. March 10, 2
2009-03-10
Preferentially substituted calcium channel blockers
Grant 7,064,128 - Snutch , et al. June 20, 2
2006-06-20
Calcium channel blockers comprising two benzhydril moieties
App 20060084660 - Snutch; Terrance P. ;   et al.
2006-04-20
Urea derivatives as calcium channel blockers
App 20060063775 - Pajouhesh; Hassan ;   et al.
2006-03-23
Diarylamine derivatives as calcium channel blockers
App 20050227999 - Pajouhesh, Hassan ;   et al.
2005-10-13
Calcium channel blockers comprising two benzhydril moieties
Grant 6,951,862 - Snutch , et al. October 4, 2
2005-10-04
Calcium channel blockers comprising two benzhydril moieties
Grant 6,949,554 - Snutch , et al. September 27, 2
2005-09-27
Calcium channel inhibitors comprising benzhydril spaced from piperazine
Grant 6,943,168 - Snutch , et al. September 13, 2
2005-09-13
N-type calcium channel blockers
App 20050014748 - Pajouhesh, Hassan ;   et al.
2005-01-20
Calcium channel inhibitors comprising benzhydril spaced from piperazine
App 20040044004 - Snutch, Terrance P. ;   et al.
2004-03-04
Calcium channel inhibitors comprising benzhydril spaced from piperazine
App 20040034035 - Snutch, Terrance P. ;   et al.
2004-02-19
Preferentially substituted calcium channel blockers
Grant 6,617,322 - Snutch September 9, 2
2003-09-09
Partially saturated calcium channel blockers
Grant 6,492,375 - Snutch December 10, 2
2002-12-10
Preferentially substituted calcium channel blockers
Grant 6,387,897 - Snutch May 14, 2
2002-05-14
Fused ring calcium channel blockers
Grant 6,310,059 - Snutch October 30, 2
2001-10-30
Calcium channel blockers
Grant 6,011,035 - Snutch , et al. January 4, 2
2000-01-04
Pro-cytotoxic drug conjugates for anticancer therapy
Grant 5,502,037 - Kondratyev March 26, 1
1996-03-26
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed